Performance Characteristics of MR Imaging in the Evaluation of Clinically Low-Risk Prostate Cancer: A Prospective Study
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Performance Characteristics of MR Imaging in the Evaluation of Clinically Low-Risk Prostate Cancer: A Prospective Study
Authors
Keywords
-
Journal
RADIOLOGY
Volume 265, Issue 2, Pages 478-487
Publisher
Radiological Society of North America (RSNA)
Online
2012-09-06
DOI
10.1148/radiol.12120041
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer
- (2011) Amita Shukla-Dave et al. BJU INTERNATIONAL
- Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer
- (2011) Hashim U. Ahmed et al. BJU INTERNATIONAL
- Evolution from active surveillance to focal therapy in the management of prostate cancer
- (2011) Uri Lindner et al. Future Oncology
- Multiparametric MRI is helpful to predict tumor focality, stage and size in patients diagnosed with unilateral low-risk prostate cancer
- (2011) N B Delongchamps et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Diffusion-weighted Endorectal MR Imaging at 3 T for Prostate Cancer: Tumor Detection and Assessment of Aggressiveness
- (2011) Hebert Alberto Vargas et al. RADIOLOGY
- Endorectal T2-weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate cancer who would qualify for active surveillance
- (2011) Thomas J. Guzzo et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Magnetic resonance imaging does not improve the prediction of misclassification of prostate cancer patients eligible for active surveillance when the most stringent selection criteria are based on the saturation biopsy scheme
- (2010) Guillaume Ploussard et al. BJU INTERNATIONAL
- Careful Selection and Close Monitoring of Low-Risk Prostate Cancer Patients on Active Surveillance Minimizes the Need for Treatment
- (2010) Mark S. Soloway et al. EUROPEAN UROLOGY
- MRI for men undergoing active surveillance or with rising PSA and negative biopsies
- (2010) Orit Raz et al. Nature Reviews Urology
- Is Apparent Diffusion Coefficient Associated with Clinical Risk Scores for Prostate Cancers that Are Visible on 3-T MR Images?
- (2010) Baris Turkbey et al. RADIOLOGY
- Interactive dedicated training curriculum improves accuracy in the interpretation of MR imaging of prostate cancer
- (2009) Oguz Akin et al. EUROPEAN RADIOLOGY
- Critical review of prostate cancer predictive tools
- (2009) Shahrokh F Shariat et al. Future Oncology
- Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate Cancer
- (2009) Laurence Klotz et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Stage T1c Prostate Cancer: Evaluation with Endorectal MR Imaging and MR Spectroscopic Imaging
- (2009) Jingbo Zhang et al. RADIOLOGY
- Prostate Cancer: Sextant Localization at MR Imaging and MR Spectroscopic Imaging before Prostatectomy—Results of ACRIN Prospective Multi-institutional Clinicopathologic Study
- (2009) Jeffrey C. Weinreb et al. RADIOLOGY
- Focal Treatment or Observation of Prostate Cancer: Pretreatment Accuracy of Transrectal Ultrasound Biopsy and T2-weighted MRI
- (2009) Lucas Nogueira et al. UROLOGY
- The clinical management of patients with a small volume of prostatic cancer on biopsy: What are the risks of progression?
- (2008) Patricia Harnden et al. CANCER
- Active surveillance for the management of prostate cancer in a contemporary cohort
- (2008) Marc A. Dall'Era et al. CANCER
- Outcomes of Men with Screen-Detected Prostate Cancer Eligible for Active Surveillance Who Were Managed Expectantly
- (2008) Roderick C.N. van den Bergh et al. EUROPEAN UROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started